Optimizing the role of FDG PET–CT for potentially operable metastatic colorectal cancer

被引：0
作者：
A. D. Culverwell
F. U. Chowdhury
A. F. Scarsbrook
机构：
[1] Leeds Teaching Hospitals NHS Trust,Departments of Clinical Radiology and Nuclear Medicine
[2] St James’s University Hospital,Department of Nuclear Medicine
来源：
Abdominal Imaging | 2012年 / 37卷
关键词：
Colonic carcinoma; Rectal carcinoma; Fluorine fluorodeoxyglucose; Positron emission tomography–computed tomography; Metastatic disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent treatment advances now allow a realistic chance of cure in selected patients with metastatic colorectal carcinoma (CRC). Accurate pre-treatment staging is crucial to ensure appropriate management by identification of patients with more advanced disease who will not benefit from surgery. 18Fluorine 2-fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography (PET–CT) has a firmly established role in staging, restaging, and recurrence detection of a range of tumors. This article will review the role of PET–CT in patients with CRC with a particular emphasis on optimizing the technique in patients with potentially operable metastatic disease.
引用
收藏
页码：1021 / 1031
页数：10
相关论文
共 254 条
[71]  
Delbeke D(2008)Ability of Am J Roentgenol 191 1436-S120
[72]  
Martin WH(2009)F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations Eur J Nucl Med Mol Imaging 36 S113-535
[73]  
Selzner M(2010)Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and non diagnostic radiologic workup Clin Radiol 65 522-1606
[74]  
Hany TF(2003)Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen Gut 52 1602-359
[75]  
Wildbrett P(2011)Early detection of recurrence by Radiother Oncol 98 357-883
[76]  
Gambhir SS(2007)FDG-PET in the follow-up of patients with colorectal cancer Eur J Nucl Med Mol Imaging 34 878-2600
[77]  
Czernin J(2006)FDG PET in preoperative assessment of colorectal liver metastases combining “evidence-based practice” and “technology assessment” methods to develop departmental imaging protocols: should FDG PET be routinely used in the pre-operative assessment of patients with colorectal liver metastases? JAMA 296 2590-undefined
[78]  
Schwimmer J(undefined)Use of a decision analysis model to assess the cost-effectiveness of undefined undefined undefined-undefined
[79]  
Ruers T(undefined)F-FDG PET in the management of metachronous liver metastases of colorectal cancer undefined undefined undefined-undefined
[80]  
Langenhoff B(undefined)Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases undefined undefined undefined-undefined
3456789101112